OXNARD, Calif., March 06, 2017 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “Company”), a leading disruptive drug delivery technology company serving the pharmaceutical, …
CURE Pharmaceutical (CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the CURE and the CannaKids partnership …
OXNARD, Calif., June 27, 2017 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, …
Anyone who’s looked at the science behind medical marijuana will suspect that the answer to the question is “yes”, and those of you in possession …
MONTREAL, May 30, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly-owned subsidiary Biocannabix …
By submitting you agree to the Terms of Service. You will receive periodic emails from Ryland Pharms and can update your email preferences at any time.
